TEODORI, ELISABETTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.734
EU - Europa 10.518
AS - Asia 7.920
SA - Sud America 796
AF - Africa 220
OC - Oceania 141
Continente sconosciuto - Info sul continente non disponibili 4
Totale 36.333
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.541
RU - Federazione Russa 3.641
SG - Singapore 2.306
CN - Cina 1.899
PL - Polonia 1.614
HK - Hong Kong 1.232
IE - Irlanda 1.027
IT - Italia 1.007
SE - Svezia 957
VN - Vietnam 870
KR - Corea 714
BR - Brasile 639
DE - Germania 545
FI - Finlandia 414
UA - Ucraina 383
FR - Francia 322
IN - India 275
GB - Regno Unito 259
JP - Giappone 153
AU - Australia 139
CA - Canada 107
CH - Svizzera 86
TR - Turchia 70
BD - Bangladesh 65
NL - Olanda 64
JO - Giordania 59
ES - Italia 57
AR - Argentina 56
ID - Indonesia 54
MX - Messico 51
CI - Costa d'Avorio 49
IQ - Iraq 48
ZA - Sudafrica 45
BE - Belgio 41
CO - Colombia 26
PK - Pakistan 25
NG - Nigeria 24
EC - Ecuador 19
RO - Romania 19
VE - Venezuela 18
MA - Marocco 17
SC - Seychelles 17
UZ - Uzbekistan 16
CL - Cile 15
AZ - Azerbaigian 13
SA - Arabia Saudita 13
AT - Austria 12
DZ - Algeria 11
KE - Kenya 11
LT - Lituania 11
PH - Filippine 11
PY - Paraguay 11
TN - Tunisia 11
BJ - Benin 10
CZ - Repubblica Ceca 10
TH - Thailandia 10
TW - Taiwan 10
HU - Ungheria 9
EG - Egitto 8
IL - Israele 8
MY - Malesia 8
NP - Nepal 8
LB - Libano 7
CR - Costa Rica 6
JM - Giamaica 6
KZ - Kazakistan 6
PT - Portogallo 6
SN - Senegal 6
DK - Danimarca 5
HR - Croazia 5
OM - Oman 5
PE - Perù 5
AM - Armenia 4
KG - Kirghizistan 4
MO - Macao, regione amministrativa speciale della Cina 4
MU - Mauritius 4
NI - Nicaragua 4
TT - Trinidad e Tobago 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
BG - Bulgaria 3
BH - Bahrain 3
BY - Bielorussia 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
IR - Iran 3
LV - Lettonia 3
PA - Panama 3
SK - Slovacchia (Repubblica Slovacca) 3
BO - Bolivia 2
CY - Cipro 2
EU - Europa 2
GD - Grenada 2
GE - Georgia 2
GR - Grecia 2
LK - Sri Lanka 2
LY - Libia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
Totale 36.308
Salva come PNG Salva come JPEG
Città #
Santa Clara 3.809
Ashburn 1.702
Singapore 1.645
Warsaw 1.601
Fairfield 1.135
Chandler 1.075
Dublin 1.021
Hong Kong 1.020
Seoul 682
Jacksonville 551
Woodbridge 519
Cambridge 498
San Jose 495
Seattle 463
Houston 457
Wilmington 412
Hefei 395
Beijing 376
Buffalo 304
Los Angeles 274
The Dalles 271
Ann Arbor 264
Princeton 241
Ho Chi Minh City 220
Munich 219
Florence 199
Boston 198
Dong Ket 193
Lauterbourg 192
Altamura 180
Hanoi 173
Council Bluffs 163
Mumbai 162
Lawrence 150
Tokyo 148
Helsinki 140
Dallas 134
Melbourne 133
Moscow 126
Boardman 123
New York 108
Medford 92
Shanghai 90
Kent 82
Bern 71
San Diego 65
Paris 61
São Paulo 56
Turku 54
Abidjan 49
Milan 49
Phoenix 45
Clifton 43
Guangzhou 42
Redondo Beach 42
Norwalk 41
Frankfurt am Main 38
Jakarta 38
Washington 37
Izmir 36
Orem 36
London 34
Falls Church 33
Brussels 32
Montreal 32
Da Nang 31
Haiphong 30
Rome 30
Hillsboro 29
Lappeenranta 29
Barcelona 28
Philadelphia 27
Toronto 27
Andover 26
Frankfurt Am Main 25
Johannesburg 24
Abuja 23
Baghdad 23
Chicago 23
Bengaluru 22
Brooklyn 22
Tianjin 22
West Jordan 22
Chennai 21
San Francisco 20
Seongnam 20
Stockholm 20
Verona 20
Yubileyny 19
Atlanta 17
Denver 16
Mexico City 15
Amsterdam 14
Redwood City 14
Rio de Janeiro 14
Shenzhen 14
Tashkent 14
Belo Horizonte 13
Brasília 13
Curitiba 13
Totale 24.109
Salva come PNG Salva come JPEG
Nome #
Molecular simplification of 1,4-diazabicyclo[4.3.0]nonan-9-ones gives piperazine derivatives that maintain high nootropic activity 408
4-Aminopiperidine derivatives as a new class of potent cognition enhancing drugs 401
S(-)ET126: a potent and selective M1 antagonist in vitro and in vivo 355
The functions and structure of ABC transporters: implications for the design of new inhibitors of Pgp and MRP1 to control multidrug resistance (MDR) 318
New Histamine-Related Five-Membered N-Heterocycle Derivatives as Carbonic Anhydrase I Activators 299
Presynaptic Cholinergic Modulators as Potent Cognition Enhancers and Analgesic Drugs. 2. 2-Phenoxy-, 2-(phenylthio)- and 2-(phenylamino)alkanoic Acid Esters 294
Design, synthesis and preliminary pharmacological evaluation of 1,4-diazabicyclo[4.3.0]nonan-9-ones as a new class of highly potent nootropic drugs. 293
Novel functionalized organotellurides with enhanced thiol peroxidase catalytic activity 288
An easy one-step procedure for the synthesis of novel beta-functionalised tellurides 280
2-Benzylpiperazine: a new scaffold for potent human Carbonic Anhydrase inhibitors. Synthesis, enzyme inhibition, enantioselectivity, computational and crystallographic studies and in vivo activity for a new class of intraocular pressure lowering agents. 272
Amino acids as building blocks for carbonic anhydrase inhibitors 267
Design, synthesis and biological evaluation of stereo- and regioisomers of amino aryl esters as multidrug resistance (MDR) reversers 265
N,N-bis(cyclohexanol)amine aryl esters: the discovery of a new class of highly potent inhibitors of transporter-dependent multidrug resistance (MDR) 263
THE FROZEN ANALOG APPROACH IN MEDICINAL CHEMISTRY 260
1,3-oxathiolane muscarinic ligands modified at the cationic head. 243
Are the contractions of rabbit peripheral lung, guinea-pig gall-bladder and guinea-pig uterus mediated by identical receptor subtype? 239
Binding Profiles of a Series of 2-Arylpropionic Acid Esters on Cloned Human Muscarinic Receptors Subtypes (m1-m5) and Their Relationship to Nootropic Activity 236
Recent advances in the search of BCRP- and dual P-gp/BCRP-based multidrug resistance modulators 235
Modulation of the spacer in N,N-bis(alkanol)amine aryl ester heterodimers led to the discovery of a series of highly potent P-glycoprotein-based multidrug-resistance (MDR) modulators 233
Design, synthesis and preliminary biological evaluation of new isoform-selective f-current blockers. 232
1-benzyl-1,4-diazepane reduces the efflux of resistance-nodulation-cell division pumps in Escherichia coli 229
Arylamino Esters as P-Glycoprotein Modulators: SAR Studies to Establish Requirements for Potency and Selectivity 227
Multidrug resistance (MDR) reversers: High activity and efficacy in a series of asymmetrical N,N-bis(alkanol)amine aryl esters 223
6,7-Dimethoxy-2-phenethyl-1,2,3,4-tetrahydroisoquinoline amides and corresponding ester isosteres as multidrug resistance reversers 221
N,N-Bis(cyclohexanol) amine aryl esters inhibit P-glycoprotein as transport substrates 217
(1,3-Dioxolane)- and (1,3-oxathiolane)-2-pyrrolidines: molecular hybrids with potential anti-Alzheimer activity 216
Metformin reacts directly with glucose following the Maillard reaction pathway 214
13C NMR SPECTRA OF 1,3-OXATHIOLANE, 1,3-OXATHIOLANE-3-OXIDE AND 1,3-OXATHIOLANE-3,3-DIOXIDE DERIVATIVES 213
Synthesis and carbonic anhydrase activating properties of a series of 2-amino-imidazolines structurally related to clonidine 209
N,N-bis(cyclohexanol)amine aryl esters: a new class of highly potent Pgp-dependent multidrug resistance (MDR) inhibitors 208
2-(2-Hydroxyethyl)piperazine derivatives as potent human carbonic anhydrase inhibitors: Synthesis, enzyme inhibition, computational studies and antiglaucoma activity 208
FURTHER STRUCTURE-ACTIVITY RELATIONSHIPS IN THE SERIES OF TROPANYL ESTERS ENDOWED WITH POTENT ANTINOCICEPTIVE ACTIVITY 206
1,4-Diazabicyclo[4.3.0]nonan-9-ones and 1,4-diamidopiperazines as new classes of highly potent nootropic drugs 206
Dual P-glycoprotein and CA XII inhibitors: A new strategy to reverse the P-gp Mediated Multidrug Resistance (MDR) in cancer cells y 205
Design, Synthesis, and Preliminary Pharmacological Evaluation of New Quinoline Derivatives as Nicotinic Ligands 205
Design, synthesis and preliminary biological evaluation of zatebradine analogues as potential blockers of the hyperpolarization-activated current 204
Highly chiral muscarinic ligands: the discovery of (2S,2'R,3'S,5'R)-1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine 3-sulfoxide methyl iodide, a potent, functionally selective, M2 partial agonist. 204
SEMI-RIGID ANALOGUES OF THE CALCIUM ANTAGONIST VERAPAMIL: A MOLECULAR MODELLING STUDY 203
ISOMERIC N,N-BIS(CYCLOHEXANOL)AMINE ARYL ESTERS: THE DISCOVERY OF A NEW CLASS OF HIGHLY POTENT P-GLYCOPROTEIN (PGP)-DEPENDENT MULTIDRUG RESISTANCE (MDR) INHIBITORS 202
Design and synthesis of new potent N,N-bis(arylalkyl)piperazine derivatives as multidrug resistance (MDR) reversing agents 202
1H-pyrrolo[2,3-b]pyridine: a new scaffold for human neutrophil elastase (HNE) inhibitors 202
Design, synthesis and nootropic activity of new analogues of sunifiram and sapunifiram, two potent cognition-enhancers. 200
Energy resolved tandem mass spectrometry experiments for resolution of isobaric compounds: a case of cis/trans isomerism 200
Antagonisti muscarinici a struttura 1,3-ossatiolano-2-pirrolidinica 197
Carbachol dimers as homobivalent modulators of muscarinic receptors 195
ANALGESIC, ANTIMUSCARINIC ACTIVITY AND ENANTIOSELECTIVITY OF THE FOUR ISOMERS OF 3-QUINUCLIDINYL TROPATE AS COMPARED WITH THE ENANTIOMERS OF HYOSCYAMINE 194
New structure–activity relationship studies in a series of N,N-bis(cyclohexanol)amine aryl esters as potent reversers of P-glycoprotein-mediated multidrug resistance (MDR) 194
SYNTHESIS, AFFINITY PROFILE AND FUNCTIONAL ACTIVITY OF MUSCARINIC ANTAGONISTS WITH A 1-METHYL-2-(2,2-ALKYLARYL-1,3-OXATHIOLAN-5-YL)PYRROLIDINE STRUCTURE 193
Synthesis and Enantioselectivity of the Enantiomers of PG9 and SM21, New Potent Analgesic and Cognition-Enhancing Drugs 189
Design and synthesis of aminoester heterodimers containing flavone or chromone moieties as modulators of P-glycoprotein-based multidrug resistance (MDR) 188
1,5,6,7-Tetrahydro-4H-indazol-4-ones as human neutrophil elastase (HNE) inhibitors 188
Design, synthesis and preliminary evaluation of a series of histone deacetylase inhibitors carrying a benzodiazepine ring 186
Aminoarylesters as multidrug resistance (MDR) reverting agents endowed with high potency and efficacy 185
1,4-Diazabicyclo[4.3.0]nonan-9-ones as a new class of highly potent nootropic drugs 184
In vitro and in silico analysis of the vascular effects of asymmetrical N,N-bis(alkanol)amine aryl esters, novel multidrug resistance-reverting agents 182
Synthesis and Cholinergic Affinity of Diastereomeric and Enantiomeric Isomers of 1-Methyl-2-(2-methyl-1,3-dioxolan-4-yl)-pyrrolidine, 1-Methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine and of Their Iodomethylates 182
Designing selective modulators for the nicotinic receptor subtypes: challenges and opportunities 181
N,N-bis(alkanol)amine aryl esters and N,N-bis(cyclohexanol)amine aryl esters: Idantification of a new class of Pgp-dependent multidrug resistance (MDR) reverters andowed with potencies in the nanomolar range 180
SYNTHESIS AND BIOLOGICAL ACTIVITY OF A SERIES OF ARYL TROPANYL ESTERS AND AMIDES CHEMICALLY RELATED TO 1H-INDOLE-3-CARBOXYLIC ACID ENDO 8-METHYL-8-AZABICYCLO[3.2.1]OCT-3-YL ESTER 178
New phenylalkylamines as isoform selective HCN-Channels blockers 178
ERMS EXPERIMENTS FOR RESOLUTION OF ISOBARIC COMPOUNDS: A CASE OF CIS/TRANS ISOMERISM 178
New dual P-Glycoprotein (P-gp) and human carbonic anhydrase XII (hCA XII) inhibitors as Multidrug Resistance (MDR) reversers in cancer cells 177
Recent advances in the discovery of Nicotinic acetylcholine receptor allosteric modulators 177
Piperazines as nootropic agents: New derivatives of the potent cognition-enhancer DM235 carrying hydrophilic substituents 177
Chiral synthesis and pharmacological evaluation of the enantiomers of SM32, a new analgesic and cognition-enhancing agent. 176
DIFFERENTIAL ANALGESIC ACTIVITY OF THE ENANTIOMERS OF ATROPINE DERIVATIVES DOES NOT CORRELATE WITH THEIR MUSCARINIC SUBTYPE SELECTIVITY 176
Design of novel nicotinic ligands through 3D database searching 175
Design, synthesis and preliminary pharmacological evaluation of new piperidine and piperazine derivatives as cognition-enhancers 174
Design, synthesis and pharmacological evaluation of some frozen-analogues of DMPP 174
N-alkanol-N-cyclohexanol amine aryl esters: Multidrug resistance (MDR) reversing agents with high potency and efficacy 174
EC18 as a Tool To Understand the Role of HCN4 Channels in Mediating Hyperpolarization-Activated Current in Tissues 174
Isomers Recognition in HPLC-MS/MS Analysis of Human Plasma Samples by Using an Ion Trap Supported by a Linear Equations-Based Algorithm 172
Diphenylcyclohexylamine derivatives as new potent multidrug resistance (MDR) modulators 172
P-glycoprotein and carbonic anhydrases hybrid inhibitors: a new strategy to reverse multidrug resistance (MDR) in cancer cells 172
PRESYNAPTIC AUTO- AND HETERO-RECEPTORS IN THE CHOLINERGIC REGULATION OF PAIN 170
SAR STUDIES ON THE POTENT AND SELECTIVE MUSCARINIC ANTAGONIST 2-ETHYLTHIO-2,2-DIPHENYLACETIC ACID N,N-DIETHYLAMINOETHYL ESTER 169
"Synthesis and binding properties of photoactivable Biotin-conjugated verapamil derivatives for the study of P-170 glycoprotein" 169
Application of LEDA Algorithm for the characterization of Isomers in Simultaneous Degradation Study in Human Plasma by HPLC-MS/MS 166
2- or 3-Substituted piperazines as nootropic agents: carbethoxy and hydroxymethyl analogues of the cognition-enhancer DM235 166
Design, synthesis and preliminary pharmacological evaluation of new analogues of DM232 (unifiram) and DM235 (sunifiram) as cognition modulators. 166
Carbachol dimers with primary carbamate groups as homobivalent modulators of muscarinic receptors 166
MOLECULAR MODULATION OF MUSCARINIC ANTAGONISTS. SYNTHESIS AND PHARMACOLOGICAL PROFILE OF 2,2-DIPHENYL-2-ETHYLTHIOACETIC AND 3,3-DIPHENYL-3-ETHYLTHIOPROPIONIC ACID DERIVATIVES CHARACTERIZED BY A DIPEPTIDE SPACER 165
The medicinal chemistry of multidrug resistance (MDR) reversing drugs 165
Sulfonamides incorporating piperazine bioisosteres as potent human carbonic anhydrase I, II, IV and IX inhibitors 165
Inhibition of P-glycoprotein-mediated Multidrug Resistance (MDR) by N,N-bis(cyclohexanol)amine aryl esters: further restriction of molecular flexibility maintains high potency and efficacy 164
Dual Inhibitors of P-gp and Carbonic Anhydrase XII (hCA XII) against Tumor Multidrug Resistance with Piperazine Scaffold 163
ANTIAMNESIC ACTIVITY OF METOCLOPRAMIDE, CISAPRIDE AND SR-17 IN THE MOUSE PASSIVE AVOIDANCE TEST 163
STRUCTURAL DEPENDENCE OF THE ALLOSTERIC INTERACTION OF SEMI-RIGID VERAPAMIL ANALOGUES WITH DIHYDROPYRIDINE-BINDING IN KITTEN HEART 163
VERAPAMIL ANALOGUES WITH RESTRICTED MOLECULAR FLEXIBILITY: SYNTHESIS AND PHARMACOLOGICAL EVALUATION OF THE FOUR ISOMERS OF ALPHA-[1-[3-[N-[1-[2-(3,4-DIMETHOXYPHENYL)ETHYL]]-N-METHYLAMINO]CYCLOHEXYL]]-ALPHA-ISOPROPYL-3,4-DIMETHOXYBENZENEACETONITRILE 163
Design, synthesis and preliminary pharmacological evaluation of new analogues of DM232 (unifiram) and DM235 (sunifiram) as cognition modulators 163
In vitro and in silico analysis of the vascular effects of asymmetrical N,N-bis(alkanol)amine aryl esters, novel multidrug-resistance reverting agents 163
New Rigid Nicotine Analogues, Carrying a Norbornane Moiety, Are Potent Agonists of α7 and α3∗ Nicotinic Receptors 162
New 3-unsubstituted Isoxazolones as Potent Human Neutrophil Elastase Inhibitors: Synthesis and Molecular Dynamic Simulation 162
Muscarinic antagonists with multiple stereocenters: synthesis, affinity profile and functional activity of isomeric 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine sulfoxide derivatives 162
SYNTHESIS AND PHARMACOLOGICAL EVALUATION OF VERAPAMIL ANALOGS WITH RESTRICTED MOLECULAR FLEXIBILITY 160
The power of energy-resolved tandem mass spectrometry experiments for resolution of isomers: the case of drug plasma stability investigation of multidrug resistance inhibitors 160
UNEXPECTED REACTIONS OF 2-NITRO-FLUORENE-9-CARBOXYLIC ACID 159
Attività analgesica e antimuscarinica ed enantioselettività dei quattro isomeri del tropato del 3-chinuclidinolo messe a confronto con gli enantiomeri della iosciamina 159
REDUCED FLEXIBILITY ANALOGS OF ANALGESIC AND COGNITION-ENHANCING A-TROPANYL ESTERS 157
The piperazine scaffold for novel drug discovery efforts: the evidence to date 156
Totale 20.373
Salva come PNG Salva come JPEG
Categoria #
all - tutte 99.992
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 99.992
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021446 0 0 0 0 0 0 0 0 0 0 124 322
2021/20221.563 53 196 102 57 40 51 74 99 51 52 347 441
2022/20234.097 389 619 190 315 321 787 537 249 426 23 131 110
2023/20241.768 57 181 264 93 116 353 54 398 31 65 78 78
2024/202510.688 379 1.078 683 1.463 3.009 1.649 191 677 523 254 381 401
2025/202610.206 1.321 1.666 1.111 718 1.244 518 1.390 551 732 660 295 0
Totale 36.672